tPA and Proteolysis in the Neurovascular Unit
- 1 February 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 35 (2) , 354-356
- https://doi.org/10.1161/01.str.0000115164.80010.8a
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Stroke--tPA and the ClinicScience, 2003
- Profiles of Matrix Metalloproteinases, Their Inhibitors, and Laminin in Stroke PatientsStroke, 2003
- Closure of the Blood-Brain Barrier by Matrix Metalloproteinase Inhibition Reduces rtPA-Mediated Mortality in Cerebral Ischemia With Delayed ReperfusionStroke, 2003
- Thrombolytic Therapy With Recombinant Tissue Plasminogen Activator for Acute Ischemic StrokeStroke, 2003
- Pathogenic Aβ induces the expression and activation of matrix metalloproteinase‐2 in human cerebrovascular smooth muscle cellsJournal of Neurochemistry, 2003
- Amyloid β-Protein Stimulates the Expression of Urokinase-type Plasminogen Activator (uPA) and Its Receptor (uPAR) in Human Cerebrovascular Smooth Muscle CellsJournal of Biological Chemistry, 2003
- Vampire Bat Salivary Plasminogen Activator (Desmoteplase)Stroke, 2003
- Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9 Expression During Reperfusion InjuryStroke, 2002
- Matrix metalloproteinases: not-so-innocent bystanders in heart failure.Journal of Clinical Investigation, 2000
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995